Literature DB >> 3701100

Invasive mucormycosis in a non-immunocompromised patient.

G Koren, I Polacheck, H Kaplan.   

Abstract

Primary invasive cutaneous mucormycosis in a non-immunocompromised patient is described. Cultures from the infected tissues yielded a zygomycete which was identified as Saksenaea vasiformis. The patient was successfully treated with debridement of the lesion and amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701100     DOI: 10.1016/s0163-4453(86)93708-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Authors:  E Alvarez; D Garcia-Hermoso; D A Sutton; J F Cano; A M Stchigel; D Hoinard; A W Fothergill; M G Rinaldi; F Dromer; J Guarro
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Saksenaea vasiformis infections: case report and literature review.

Authors:  William Vega; Margot Orellana; Luis Zaror; Josepa Gené; Josep Guarro
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

Review 4.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis.

Authors:  A A Padhye; L Ajello
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.